These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 29592766)

  • 1. Surface contamination of counting tools after mock dispensing of cyclophosphamide in a simulated outpatient pharmacy.
    Chaffee BW; Lander MJ; Christen C; Redic KA
    J Oncol Pharm Pract; 2019 Jan; 25(1):85-93. PubMed ID: 29592766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental contamination by cyclophosphamide preparation: Comparison of conventional manual production in biological safety cabinet and robot-assisted production by APOTECAchemo.
    Schierl R; Masini C; Groeneveld S; Fischer E; Böhlandt A; Rosini V; Paolucci D
    J Oncol Pharm Pract; 2016 Feb; 22(1):37-45. PubMed ID: 25227229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation.
    Sessink PJ; Leclercq GM; Wouters DM; Halbardier L; Hammad C; Kassoul N
    J Oncol Pharm Pract; 2015 Apr; 21(2):118-27. PubMed ID: 24567041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a closed system drug-transfer device eliminates surface contamination with antineoplastic agents.
    Clark BA; Sessink PJ
    J Oncol Pharm Pract; 2013 Jun; 19(2):99-104. PubMed ID: 23292973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study comparing the efficacy of two cleaning techniques in reducing environmental contamination with cyclophosphamide.
    Touzin K; Bussières JF; Langlois E; Lefebvre M; Métra A
    Ann Occup Hyg; 2010 Apr; 54(3):351-9. PubMed ID: 20118195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application and assessment of a regular environmental monitoring of the antineoplastic drug contamination level in pharmacies - the MEWIP project.
    Kiffmeyer TK; Tuerk J; Hahn M; Stuetzer H; Hadtstein C; Heinemann A; Eickmann U
    Ann Occup Hyg; 2013 May; 57(4):444-55. PubMed ID: 23125441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot assessment of the antineoplastic drug contamination levels in British Columbian hospitals pre- and post-cleaning.
    Chu WC; Hon CY; Danyluk Q; Chua PP; Astrakianakis G
    J Oncol Pharm Pract; 2012 Mar; 18(1):46-51. PubMed ID: 21737485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact and appreciation of two methods aiming at reducing hazardous drug environmental contamination: The centralization of the priming of IV tubing in the pharmacy and use of a closed-system transfer device.
    Guillemette A; Langlois H; Voisine M; Merger D; Therrien R; Mercier G; Lebel D; Bussières JF
    J Oncol Pharm Pract; 2014 Dec; 20(6):426-32. PubMed ID: 24395542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface contamination of the outer and blister packages of oral anticancer drugs: A multicenter study.
    Nomura H; Katakura N; Morita T; Sano Y; Usui H; Hiura S; Nakakuni M; Otsuka M; Akiyama E; Endo K
    J Oncol Pharm Pract; 2020 Jan; 26(1):141-145. PubMed ID: 31132937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of decontamination strategies for cyclophosphamide.
    Soubieux A; Palamini M; Tanguay C; Bussières JF
    J Oncol Pharm Pract; 2020 Mar; 26(2):413-422. PubMed ID: 31370747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental contamination with methotrexate in Canadian community pharmacies.
    Merger D; Tanguay C; Langlois É; Lefebvre M; Bussières JF
    J Am Pharm Assoc (2003); 2013; 53(4):423-6. PubMed ID: 23892817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclophosphamide contamination observed on the external surfaces of drug vials and the efficacy of cleaning on vial contamination.
    Touzin K; Bussières JF; Langlois E; Lefebvre M; Gallant C
    Ann Occup Hyg; 2008 Nov; 52(8):765-71. PubMed ID: 18663228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the efficacy of a self-cleaning automated compounding system for the decontamination of cytotoxic drugs.
    Telleria N; García N; Grisaleña J; Algaba N; Bergareche E; Tamés MJ; Cajaraville G
    J Oncol Pharm Pract; 2021 Sep; 27(6):1343-1353. PubMed ID: 32854575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of external contamination on the vial surfaces of some hazardous drugs that commonly used in Chinese hospitals and comparison between environmental contamination generated during robotic compounding by IV: Dispensing robot vs. manual compounding in biological safety cabinet.
    Ml H; T W; Jq Z; Yj S; Tj G; Lk Z; J L; Jf Y
    J Oncol Pharm Pract; 2022 Oct; 28(7):1487-1498. PubMed ID: 34162245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre and post intervention study of antiblastic drugs contamination surface levels at a Pharmacy Department Compounding Area using a closed system drug transfer device and a decontamination process.
    Valero S; López-Briz E; Vila N; Solana A; Melero M; Poveda JL
    Regul Toxicol Pharmacol; 2018 Jun; 95():1-7. PubMed ID: 29510165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of a decontamination procedure in a pharmacy buffer room contaminated by 5 antineoplastic agents.
    Arpino P; Yeomelakis J; Oommen A
    Am J Health Syst Pharm; 2020 Dec; 77(24):2081-2088. PubMed ID: 33150407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case study: surface contamination of cyclophosphamide due to working practices and cleaning procedures in two Italian hospitals.
    Acampora A; Castiglia L; Miraglia N; Pieri M; Soave C; Liotti F; Sannolo N
    Ann Occup Hyg; 2005 Oct; 49(7):611-8. PubMed ID: 15964876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical dust exposure at pharmacies using automatic dispensing machines: a preliminary study.
    Fent KW; Durgam S; Mueller C
    J Occup Environ Hyg; 2014; 11(11):695-705. PubMed ID: 24824046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of surface contamination in a hospital hematology--oncology pharmacy.
    Touzin K; Bussières JF; Langlois E; Lefebvre M
    J Oncol Pharm Pract; 2009 Mar; 15(1):53-61. PubMed ID: 18772214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The assessment of environmental and external cross-contamination in preparing ready-to-administer cytotoxic drugs: a comparison between a robotic system and conventional manual production.
    Werumeus Buning A; Geersing TH; Crul M
    Int J Pharm Pract; 2020 Feb; 28(1):66-74. PubMed ID: 31489970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.